Tradition Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-369
Closed -$30K 701
2023
Q4
$30K Buy
369
+91
+33% +$7.08K ﹤0.01% 749
2023
Q3
$21K Buy
278
+25
+10% +$1.92K ﹤0.01% 829
2023
Q2
$19K Sell
253
-142
-36% -$11.3K ﹤0.01% 892
2023
Q1
$33K Buy
395
+5
+1% +$414 ﹤0.01% 725
2022
Q4
$33K Buy
390
+15
+4% +$1.19K ﹤0.01% 635
2022
Q3
$23K Buy
375
+165
+79% +$10.4K ﹤0.01% 719
2022
Q2
$13K Sell
210
-310
-60% -$19.2K ﹤0.01% 756
2022
Q1
$31K Buy
520
+2
+0.4% +$128 ﹤0.01% 616
2021
Q4
$38K Sell
518
-59
-10% -$4.06K ﹤0.01% 594
2021
Q3
$40K Buy
577
+52
+10% +$3.65K 0.01% 564
2021
Q2
$36K Buy
525
+2
+0.4% +$134 0.01% 618
2021
Q1
$34K Buy
523
+1
+0.2% +$64 0.01% 523
2020
Q4
$30K Buy
+522
New +$31.5K 0.01% 507

Other funds holding GILD

Tradition Wealth Management's GILD Position: Q1 2024 in Review

Tradition Wealth Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 369 shares — an estimated $30K sold.

Tradition Wealth Management first reported a position in GILD in Q4 2020 and held it in 13 quarters. The position peaked at $40K in Q3 2021. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Tradition Wealth Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • Tradition Wealth Management sold 369 Gilead Sciences shares in Q1 2024, an estimated $30K.
  • Tradition Wealth Management first reported a position in Gilead Sciences in Q4 2020 and held it in 13 quarters.
  • Tradition Wealth Management's Gilead Sciences position peaked at $40K in Q3 2021.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Tradition Wealth Management's 13F filing for Q1 2024, filed 13 May 2024.